Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis

Clinical trial NCT04523220 · COMPLETED

Trial details

NCT number: NCT04523220
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

End-stage Renal Disease Prevention of Thromboembolic Events Hemodialysis Hemodiafiltration

Start date: 2020-08-28
Primary completion: 2021-12-28
Enrollment: 704

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.